Utility of Procalcitonin in Clinical Practice

Area of Science:

• Clinical Microbiology
• Infectious Diseases
• Pharmacology

Background:

• Antibiotic overuse fuels multi-resistant infections, necessitating improved patient safety strategies.
• Antibiotic stewardship programs are crucial for quality patient care and combating antimicrobial resistance.
• Biomarkers aiding in bacterial infection diagnosis are vital for appropriate antibiotic use and discontinuation.

Purpose of the Study:

• To review the evidence supporting procalcitonin's utility in antimicrobial stewardship.
• To highlight procalcitonin's role in guiding antibiotic therapy decisions.
• To discuss the application of procalcitonin in clinical practice for infection management.

Main Methods:

• Literature review of studies on procalcitonin and antimicrobial stewardship.
• Analysis of evidence focusing on lower respiratory tract infections and sepsis.
• Synthesis of clinical practice guidelines and expert recommendations.

Main Results:

• Procalcitonin demonstrates potential as a biomarker for guiding antibiotic therapy.
• Evidence supports procalcitonin use primarily in lower respiratory tract infections and sepsis.
• Effective use of procalcitonin can lead to reduced antibiotic exposure and improved patient outcomes.

Conclusions:

• Procalcitonin is a valuable tool for enhancing antimicrobial stewardship.
• Its application can optimize antibiotic prescribing and patient management.
• Further integration of procalcitonin into clinical practice is warranted.